nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ABCC1—Dactinomycin—ocular cancer	0.524	0.805	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—ocular cancer	0.126	0.194	CbGbCtD
Diclofenac—Epidermolysis—Dactinomycin—ocular cancer	0.0544	0.376	CcSEcCtD
Diclofenac—Proctitis—Dactinomycin—ocular cancer	0.0107	0.0737	CcSEcCtD
Diclofenac—Phlebitis—Carboplatin—ocular cancer	0.0059	0.0408	CcSEcCtD
Diclofenac—Ulcerative stomatitis—Dactinomycin—ocular cancer	0.00563	0.039	CcSEcCtD
Diclofenac—Eruption—Dactinomycin—ocular cancer	0.00423	0.0292	CcSEcCtD
Diclofenac—Ulcer—Dactinomycin—ocular cancer	0.00275	0.019	CcSEcCtD
Diclofenac—Infection—Carboplatin—ocular cancer	0.00248	0.0172	CcSEcCtD
Diclofenac—Aplastic anaemia—Dactinomycin—ocular cancer	0.00244	0.0169	CcSEcCtD
Diclofenac—Oesophagitis—Dactinomycin—ocular cancer	0.00238	0.0164	CcSEcCtD
Diclofenac—Mouth ulceration—Dactinomycin—ocular cancer	0.00235	0.0163	CcSEcCtD
Diclofenac—Sepsis—Dactinomycin—ocular cancer	0.00226	0.0156	CcSEcCtD
Diclofenac—Phlebitis—Dactinomycin—ocular cancer	0.00219	0.0152	CcSEcCtD
Diclofenac—Pain—Carboplatin—ocular cancer	0.00214	0.0148	CcSEcCtD
Diclofenac—Hepatic failure—Dactinomycin—ocular cancer	0.0021	0.0145	CcSEcCtD
Diclofenac—Body temperature increased—Carboplatin—ocular cancer	0.00198	0.0137	CcSEcCtD
Diclofenac—Lethargy—Dactinomycin—ocular cancer	0.00193	0.0133	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.0017	0.0118	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.0017	0.0118	CcSEcCtD
Diclofenac—Pancytopenia—Dactinomycin—ocular cancer	0.00155	0.0107	CcSEcCtD
Diclofenac—Pneumonia—Dactinomycin—ocular cancer	0.00146	0.0101	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.00144	0.00998	CcSEcCtD
Diclofenac—Stomatitis—Dactinomycin—ocular cancer	0.00142	0.00981	CcSEcCtD
Diclofenac—Agranulocytosis—Dactinomycin—ocular cancer	0.00136	0.00939	CcSEcCtD
Diclofenac—Hepatitis—Dactinomycin—ocular cancer	0.00131	0.00904	CcSEcCtD
Diclofenac—Pharyngitis—Dactinomycin—ocular cancer	0.0013	0.00897	CcSEcCtD
Diclofenac—Erythema multiforme—Dactinomycin—ocular cancer	0.00124	0.00854	CcSEcCtD
Diclofenac—Flushing—Dactinomycin—ocular cancer	0.00121	0.00839	CcSEcCtD
Diclofenac—Chills—Dactinomycin—ocular cancer	0.00117	0.00811	CcSEcCtD
Diclofenac—Alopecia—Dactinomycin—ocular cancer	0.00115	0.00798	CcSEcCtD
Diclofenac—Erythema—Dactinomycin—ocular cancer	0.00114	0.00787	CcSEcCtD
Diclofenac—Ill-defined disorder—Dactinomycin—ocular cancer	0.00106	0.0073	CcSEcCtD
Diclofenac—Anaemia—Dactinomycin—ocular cancer	0.00105	0.00727	CcSEcCtD
Diclofenac—Malaise—Dactinomycin—ocular cancer	0.00103	0.00709	CcSEcCtD
Diclofenac—Leukopenia—Dactinomycin—ocular cancer	0.00102	0.00704	CcSEcCtD
Diclofenac—Myalgia—Dactinomycin—ocular cancer	0.000968	0.0067	CcSEcCtD
Diclofenac—Discomfort—Dactinomycin—ocular cancer	0.000957	0.00662	CcSEcCtD
Diclofenac—Oedema—Dactinomycin—ocular cancer	0.000928	0.00642	CcSEcCtD
Diclofenac—Infection—Dactinomycin—ocular cancer	0.000922	0.00638	CcSEcCtD
Diclofenac—Thrombocytopenia—Dactinomycin—ocular cancer	0.000909	0.00628	CcSEcCtD
Diclofenac—Anorexia—Dactinomycin—ocular cancer	0.000885	0.00612	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000846	0.00585	CcSEcCtD
Diclofenac—Decreased appetite—Dactinomycin—ocular cancer	0.000807	0.00558	CcSEcCtD
Diclofenac—Fatigue—Dactinomycin—ocular cancer	0.0008	0.00553	CcSEcCtD
Diclofenac—Pain—Dactinomycin—ocular cancer	0.000794	0.00549	CcSEcCtD
Diclofenac—Feeling abnormal—Dactinomycin—ocular cancer	0.000765	0.00529	CcSEcCtD
Diclofenac—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000759	0.00525	CcSEcCtD
Diclofenac—Abdominal pain—Dactinomycin—ocular cancer	0.000734	0.00507	CcSEcCtD
Diclofenac—Body temperature increased—Dactinomycin—ocular cancer	0.000734	0.00507	CcSEcCtD
Diclofenac—Hypersensitivity—Dactinomycin—ocular cancer	0.000684	0.00473	CcSEcCtD
Diclofenac—Asthenia—Dactinomycin—ocular cancer	0.000666	0.00461	CcSEcCtD
Diclofenac—Diarrhoea—Dactinomycin—ocular cancer	0.000635	0.00439	CcSEcCtD
Diclofenac—Vomiting—Dactinomycin—ocular cancer	0.00059	0.00408	CcSEcCtD
Diclofenac—Rash—Dactinomycin—ocular cancer	0.000585	0.00405	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—ocular cancer	0.000551	0.00381	CcSEcCtD
Diclofenac—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.000181	0.000883	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—GNAQ—ocular cancer	0.000181	0.000882	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—TP53—ocular cancer	0.000181	0.000881	CbGpPWpGaD
Diclofenac—UGT1A1—NRF2 pathway—TGFB1—ocular cancer	0.00018	0.000879	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PSPH—ocular cancer	0.00018	0.000879	CbGpPWpGaD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00018	0.000875	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000179	0.000872	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—E2F3—ocular cancer	0.000179	0.00087	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—E2F1—ocular cancer	0.000176	0.000857	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GNA11—ocular cancer	0.000175	0.000853	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.000173	0.000843	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000173	0.000841	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—GNA11—ocular cancer	0.000172	0.000836	CbGpPWpGaD
Diclofenac—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.000171	0.000835	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PSPH—ocular cancer	0.00017	0.000828	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000167	0.000813	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000166	0.000811	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TFDP1—ocular cancer	0.000166	0.000809	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GNAQ—ocular cancer	0.000163	0.000793	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EP300—ocular cancer	0.00016	0.000781	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—GNAQ—ocular cancer	0.00016	0.000777	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000159	0.000772	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—CDK2—ocular cancer	0.000158	0.00077	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PSPH—ocular cancer	0.000156	0.000759	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PSPH—ocular cancer	0.000155	0.000755	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TFDP1—ocular cancer	0.000155	0.000754	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—HRAS—ocular cancer	0.000154	0.000749	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—TGFB1—ocular cancer	0.000153	0.000745	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SAG—ocular cancer	0.000152	0.000738	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00015	0.00073	CbGpPWpGaD
Diclofenac—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.00015	0.000728	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—ocular cancer	0.000147	0.000715	CbGpPWpGaD
Diclofenac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000146	0.000713	CbGpPWpGaD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000146	0.000709	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—HRAS—ocular cancer	0.000145	0.000705	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—HRAS—ocular cancer	0.000145	0.000705	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HDAC1—ocular cancer	0.000144	0.000701	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.000143	0.000697	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TGFB1—ocular cancer	0.000139	0.000679	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PSPH—ocular cancer	0.000139	0.000678	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.000139	0.000676	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000138	0.000674	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000137	0.000666	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—ocular cancer	0.000137	0.000665	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PSPH—ocular cancer	0.000136	0.000662	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000135	0.000659	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000135	0.000658	CbGpPWpGaD
Diclofenac—PTGS2—Disease—E2F5—ocular cancer	0.000134	0.000653	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAML2—ocular cancer	0.000132	0.000643	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000131	0.00064	CbGpPWpGaD
Diclofenac—PTGS2—Disease—E2F4—ocular cancer	0.000131	0.00064	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000131	0.000638	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000129	0.000629	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CDKN2B—ocular cancer	0.000129	0.000628	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RPL39—ocular cancer	0.000129	0.000628	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RBL1—ocular cancer	0.000129	0.000628	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—AKT1—ocular cancer	0.000128	0.000623	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—AKT1—ocular cancer	0.000128	0.000623	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PSPH—ocular cancer	0.000127	0.000618	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000123	0.000601	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAML2—ocular cancer	0.000123	0.000599	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNA11—ocular cancer	0.00012	0.000586	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—E2F1—ocular cancer	0.000118	0.000576	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNA11—ocular cancer	0.000118	0.000574	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000118	0.000573	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNA11—ocular cancer	0.000115	0.000561	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNA11—ocular cancer	0.000115	0.000559	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000114	0.000555	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000114	0.000555	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNAQ—ocular cancer	0.000112	0.000545	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—HRAS—ocular cancer	0.00011	0.000534	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNAQ—ocular cancer	0.00011	0.000534	CbGpPWpGaD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000109	0.000529	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PSPH—ocular cancer	0.000108	0.000528	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000108	0.000528	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNAQ—ocular cancer	0.000107	0.000521	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNAQ—ocular cancer	0.000107	0.000519	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MDM2—ocular cancer	0.000106	0.000518	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000104	0.000507	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TFDP1—ocular cancer	0.000104	0.000506	CbGpPWpGaD
Diclofenac—TTR—Disease—MDM2—ocular cancer	0.000102	0.000497	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HDAC1—ocular cancer	0.000101	0.000491	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000101	0.000491	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRAS—ocular cancer	9.87e-05	0.000481	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CDKN1B—ocular cancer	9.71e-05	0.000473	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—AKT1—ocular cancer	9.69e-05	0.000472	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HDAC1—ocular cancer	9.65e-05	0.00047	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—AKT1—ocular cancer	9.6e-05	0.000468	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.58e-05	0.000467	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	9.44e-05	0.00046	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	9.42e-05	0.000459	CbGpPWpGaD
Diclofenac—TTR—Disease—CDKN1B—ocular cancer	9.33e-05	0.000454	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNA11—ocular cancer	9.32e-05	0.000454	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CCND1—ocular cancer	9.26e-05	0.000451	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HDAC1—ocular cancer	8.99e-05	0.000438	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNA11—ocular cancer	8.99e-05	0.000438	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CDKN1A—ocular cancer	8.96e-05	0.000436	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—EP300—ocular cancer	8.89e-05	0.000433	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.75e-05	0.000426	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—AKT1—ocular cancer	8.72e-05	0.000425	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNAQ—ocular cancer	8.66e-05	0.000422	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN2B—ocular cancer	8.65e-05	0.000421	CbGpPWpGaD
Diclofenac—TTR—Disease—CDKN1A—ocular cancer	8.61e-05	0.000419	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EP300—ocular cancer	8.52e-05	0.000415	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PSPH—ocular cancer	8.37e-05	0.000408	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNAQ—ocular cancer	8.35e-05	0.000407	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.34e-05	0.000406	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAML2—ocular cancer	8.25e-05	0.000402	CbGpPWpGaD
Diclofenac—TTR—Disease—EP300—ocular cancer	8.19e-05	0.000399	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	8.07e-05	0.000393	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN2B—ocular cancer	8.06e-05	0.000393	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—EP300—ocular cancer	7.98e-05	0.000388	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—E2F1—ocular cancer	7.94e-05	0.000387	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	7.75e-05	0.000378	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TGFB1—ocular cancer	7.72e-05	0.000376	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.68e-05	0.000374	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNA11—ocular cancer	7.6e-05	0.00037	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MYC—ocular cancer	7.43e-05	0.000362	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TGFB1—ocular cancer	7.41e-05	0.000361	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—CDK2—ocular cancer	7.16e-05	0.000349	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MDM2—ocular cancer	7.15e-05	0.000348	CbGpPWpGaD
Diclofenac—TTR—Disease—MYC—ocular cancer	7.14e-05	0.000348	CbGpPWpGaD
Diclofenac—TTR—Disease—TGFB1—ocular cancer	7.12e-05	0.000347	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNAQ—ocular cancer	7.06e-05	0.000344	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	6.78e-05	0.00033	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.74e-05	0.000328	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.69e-05	0.000326	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.68e-05	0.000325	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.55e-05	0.000319	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CDKN1B—ocular cancer	6.53e-05	0.000318	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—ocular cancer	6.36e-05	0.00031	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCND1—ocular cancer	6.23e-05	0.000303	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—ocular cancer	6.1e-05	0.000297	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—ocular cancer	6.08e-05	0.000296	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HDAC1—ocular cancer	6.04e-05	0.000294	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNA11—ocular cancer	6.03e-05	0.000294	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CDKN1A—ocular cancer	6.03e-05	0.000294	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—EP300—ocular cancer	5.85e-05	0.000285	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—ocular cancer	5.83e-05	0.000284	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNA11—ocular cancer	5.8e-05	0.000282	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EP300—ocular cancer	5.73e-05	0.000279	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.7e-05	0.000278	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNA11—ocular cancer	5.68e-05	0.000277	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNAQ—ocular cancer	5.61e-05	0.000273	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—ocular cancer	5.6e-05	0.000273	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.5e-05	0.000268	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN2B—ocular cancer	5.41e-05	0.000263	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNAQ—ocular cancer	5.39e-05	0.000262	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—AKT1—ocular cancer	5.37e-05	0.000262	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNA11—ocular cancer	5.35e-05	0.000261	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNAQ—ocular cancer	5.28e-05	0.000257	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKT1—ocular cancer	5.15e-05	0.000251	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MYC—ocular cancer	5e-05	0.000243	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFB1—ocular cancer	4.99e-05	0.000243	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNAQ—ocular cancer	4.98e-05	0.000242	CbGpPWpGaD
Diclofenac—TTR—Disease—AKT1—ocular cancer	4.95e-05	0.000241	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNA11—ocular cancer	4.91e-05	0.000239	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNA11—ocular cancer	4.88e-05	0.000238	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AKT1—ocular cancer	4.82e-05	0.000235	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MDM2—ocular cancer	4.8e-05	0.000234	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	4.71e-05	0.00023	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.64e-05	0.000226	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNAQ—ocular cancer	4.56e-05	0.000222	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNAQ—ocular cancer	4.54e-05	0.000221	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.52e-05	0.00022	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MDM2—ocular cancer	4.47e-05	0.000218	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—ocular cancer	4.46e-05	0.000217	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNA11—ocular cancer	4.38e-05	0.000213	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1B—ocular cancer	4.38e-05	0.000213	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—ocular cancer	4.33e-05	0.000211	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNA11—ocular cancer	4.28e-05	0.000208	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—ocular cancer	4.18e-05	0.000204	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—ocular cancer	4.1e-05	0.0002	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1B—ocular cancer	4.08e-05	0.000199	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNAQ—ocular cancer	4.07e-05	0.000198	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1A—ocular cancer	4.04e-05	0.000197	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—EP300—ocular cancer	4.02e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.02e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNA11—ocular cancer	3.99e-05	0.000195	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNAQ—ocular cancer	3.97e-05	0.000194	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—EP300—ocular cancer	3.94e-05	0.000192	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—ocular cancer	3.93e-05	0.000192	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—ocular cancer	3.92e-05	0.000191	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EP300—ocular cancer	3.85e-05	0.000187	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—EP300—ocular cancer	3.83e-05	0.000187	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1A—ocular cancer	3.77e-05	0.000184	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAQ—ocular cancer	3.71e-05	0.000181	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.68e-05	0.000179	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.66e-05	0.000178	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EP300—ocular cancer	3.59e-05	0.000175	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—ocular cancer	3.54e-05	0.000172	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—ocular cancer	3.5e-05	0.00017	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—ocular cancer	3.47e-05	0.000169	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNA11—ocular cancer	3.41e-05	0.000166	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—ocular cancer	3.35e-05	0.000163	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—ocular cancer	3.34e-05	0.000163	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.29e-05	0.00016	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAQ—ocular cancer	3.17e-05	0.000155	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—ocular cancer	3.12e-05	0.000152	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—ocular cancer	3.12e-05	0.000152	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—ocular cancer	3.11e-05	0.000152	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—ocular cancer	3e-05	0.000146	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—ocular cancer	3e-05	0.000146	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3e-05	0.000146	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—ocular cancer	2.88e-05	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—ocular cancer	2.75e-05	0.000134	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—ocular cancer	2.75e-05	0.000134	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—ocular cancer	2.74e-05	0.000133	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNA11—ocular cancer	2.63e-05	0.000128	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—ocular cancer	2.63e-05	0.000128	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.56e-05	0.000125	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—ocular cancer	2.54e-05	0.000124	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—ocular cancer	2.53e-05	0.000123	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—ocular cancer	2.45e-05	0.000119	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAQ—ocular cancer	2.45e-05	0.000119	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—ocular cancer	2.43e-05	0.000118	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—ocular cancer	2.41e-05	0.000117	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—ocular cancer	2.38e-05	0.000116	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—ocular cancer	2.32e-05	0.000113	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—ocular cancer	2.32e-05	0.000113	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—ocular cancer	2.17e-05	0.000106	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—ocular cancer	2.1e-05	0.000102	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—ocular cancer	2.09e-05	0.000102	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—ocular cancer	2.02e-05	9.81e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—ocular cancer	1.94e-05	9.43e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—ocular cancer	1.9e-05	9.24e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—ocular cancer	1.88e-05	9.16e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—ocular cancer	1.81e-05	8.84e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—ocular cancer	1.79e-05	8.71e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—ocular cancer	1.65e-05	8.02e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—ocular cancer	1.64e-05	7.99e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—ocular cancer	1.63e-05	7.94e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—ocular cancer	1.53e-05	7.47e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—ocular cancer	1.46e-05	7.13e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—ocular cancer	1.45e-05	7.08e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—ocular cancer	1.43e-05	6.96e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—ocular cancer	1.33e-05	6.5e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—ocular cancer	1.22e-05	5.93e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—ocular cancer	1.17e-05	5.7e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—ocular cancer	1.15e-05	5.58e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—ocular cancer	1.14e-05	5.55e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—ocular cancer	1.08e-05	5.26e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—ocular cancer	9.91e-06	4.83e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—ocular cancer	9.85e-06	4.8e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—ocular cancer	8.84e-06	4.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—ocular cancer	8.8e-06	4.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—ocular cancer	8.63e-06	4.2e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—ocular cancer	8.06e-06	3.93e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—ocular cancer	6.89e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—ocular cancer	5.32e-06	2.59e-05	CbGpPWpGaD
